ProShare Advisors’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-14,334
| Closed | -$1.39M | – | 1821 |
|
|
2019
Q3 | $1.39M | Sell |
14,334
-931
| -6% | -$90.3K | 0.01% | 669 |
|
|
2019
Q2 | $1.56M | Sell |
15,265
-1,330
| -8% | -$136K | 0.01% | 642 |
|
|
2019
Q1 | $1.89M | Buy |
16,595
+488
| +3% | +$55.6K | 0.01% | 612 |
|
|
2018
Q4 | $630K | Sell |
16,107
-3,063
| -16% | -$120K | ﹤0.01% | 868 |
|
|
2018
Q3 | $1.05M | Sell |
19,170
-685
| -3% | -$37.4K | 0.01% | 805 |
|
|
2018
Q2 | $1.64M | Sell |
19,855
-886
| -4% | -$73.3K | 0.01% | 663 |
|
|
2018
Q1 | $1.38M | Sell |
20,741
-3,297
| -14% | -$220K | 0.01% | 713 |
|
|
2017
Q4 | $1.24M | Buy |
24,038
+1,636
| +7% | +$84.1K | 0.01% | 758 |
|
|
2017
Q3 | $2M | Buy |
22,402
+4,370
| +24% | +$390K | 0.02% | 558 |
|
|
2017
Q2 | $1.08M | Sell |
18,032
-739
| -4% | -$44.1K | 0.01% | 715 |
|
|
2017
Q1 | $1M | Sell |
18,771
-4,630
| -20% | -$247K | 0.01% | 745 |
|
|
2016
Q4 | $1.17M | Buy |
23,401
+1,790
| +8% | +$89.3K | 0.01% | 711 |
|
|
2016
Q3 | $1.3M | Sell |
21,611
-882
| -4% | -$53K | 0.02% | 618 |
|
|
2016
Q2 | $1.15M | Buy |
22,493
+1,372
| +6% | +$70.1K | 0.01% | 676 |
|
|
2016
Q1 | $623K | Buy |
21,121
+75
| +0.4% | +$2.21K | 0.01% | 904 |
|
|
2015
Q4 | $954K | Buy |
+21,046
| New | +$954K | 0.01% | 754 |
|